Conclusion: HNRNPA1-mediated exosomal transfer of miR-320 from leukemia cells to BMMSC is an important mediator of leukemia progression and is a potential therapeutic target for CML. This evidence concerns the gene HNRNPA1 and chronic myelogenous leukemia, BCR-ABL1 positive.